ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth

Activin receptor–like kinase-1 (ALK1) is a type I, endothelial cell–specific member of the transforming growth factor-β superfamily of receptors known to play an essential role in modulating angiogenesis and vessel maintenance. In the present study, we sought to examine the angiogenic and tumorigenic effects mediated upon the inhibition of ALK1 signaling using a soluble chimeric protein (ALK1-Fc). Of 29 transforming growth factor-β–related ligands screened by surface plasmon resonance, only bone morphogenetic protein (BMP9) and BMP10 displayed high-affinity binding to ALK1-Fc. In cell-based assays, ALK1-Fc inhibited BMP9-mediated Id-1 expression in human umbilical vein endothelial cells and inhibited cord formation by these cells on a Matrigel substrate. In a chick chorioallantoic membrane assay, ALK1-Fc reduced vascular endothelial growth factor–, fibroblast growth factor–, and BMP10-mediated vessel formation. The growth of B16 melanoma explants was also inhibited significantly by ALK1-Fc in this assay. Finally, ALK1-Fc treatment reduced tumor burden in mice receiving orthotopic grafts of MCF7 mammary adenocarcinoma cells. These data show the efficacy of chimeric ALK1-Fc proteins in mitigating vessel formation and support the view that ALK1-Fc is a powerful antiangiogenic agent capable of blocking vascularization. Mol Cancer Ther; 9(2); 379–

[1]  Xiaohui Xu,et al.  Inhibitor of DNA Binding-1 Overexpression in Prostate Cancer: Relevance to Tumor Differentiation , 2009, Pathology & Oncology Research.

[2]  F. Stewart,et al.  Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. , 2009, International journal of radiation oncology, biology, physics.

[3]  L. David,et al.  Bone Morphogenetic Protein-9 Is a Circulating Vascular Quiescence Factor , 2008, Circulation research.

[4]  C. Foster,et al.  Increased Expression of Id Family Proteins in Small Cell Lung Cancer and its Prognostic Significance , 2008, Clinical Cancer Research.

[5]  Hong Zhang,et al.  Overexpression of Id-1 protein is a marker in colorectal cancer progression. , 2008, Oncology reports.

[6]  V. Kaartinen,et al.  ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. , 2008, Blood.

[7]  Edi Brogi,et al.  ID genes mediate tumor reinitiation during breast cancer lung metastasis , 2007, Proceedings of the National Academy of Sciences.

[8]  J. López-Novoa,et al.  Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia. , 2007, Human molecular genetics.

[9]  M. V. Dinther,et al.  BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis , 2007, Journal of Cell Science.

[10]  L. David,et al.  Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. , 2007, Blood.

[11]  P. P. Sayeski,et al.  ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKCzeta-controlled ERK1/2 activity within the nucleus. , 2006, American journal of physiology. Cell physiology.

[12]  R. Pyeritz,et al.  SMAD4 mutations found in unselected HHT patients , 2006, Journal of Medical Genetics.

[13]  Xiaomeng Zhang,et al.  Significance of Id-1 up-regulation and its association with EGFR in bladder cancer cell invasion. , 2006, International journal of oncology.

[14]  Y. Wong,et al.  Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). , 2005, Carcinogenesis.

[15]  Mallika Singh,et al.  Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors* , 2005, Journal of Biological Chemistry.

[16]  M. Letarte,et al.  Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease , 2005, Journal of Medical Genetics.

[17]  T. Seki,et al.  Arterial Endothelium-Specific Activin Receptor-Like Kinase 1 Expression Suggests Its Role in Arterialization and Vascular Remodeling , 2003, Circulation research.

[18]  Jonas Larsson,et al.  Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. , 2003, Molecular cell.

[19]  W. Kwiatkowski,et al.  The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.

[20]  M. Porteous,et al.  A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. , 2003, Human molecular genetics.

[21]  Samy Lamouille,et al.  Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. , 2002, Blood.

[22]  O. Volpert,et al.  Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. , 2002, Cancer cell.

[23]  M. Goumans,et al.  Stimulation of Id1 Expression by Bone Morphogenetic Protein Is Sufficient and Necessary for Bone Morphogenetic Protein–Induced Activation of Endothelial Cells , 2002, Circulation.

[24]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[25]  Dean Y. Li,et al.  Arteriovenous malformations in mice lacking activin receptor-like kinase-1 , 2000, Nature Genetics.

[26]  T. Kirsch,et al.  BMP‐2 antagonists emerge from alterations in the low‐affinity binding epitope for receptor BMPR‐II , 2000, The EMBO journal.

[27]  P. Donahoe,et al.  Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Guttmacher,et al.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). , 2000, American journal of medical genetics.

[29]  P. Lastres,et al.  Endoglin overexpression modulates cellular morphology, migration, and adhesion of mouse fibroblasts. , 1999, European journal of cell biology.

[30]  C. Mummery,et al.  Expression of ALK‐1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development , 1997, Developmental dynamics : an official publication of the American Association of Anatomists.

[31]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[32]  太田 樹.  Targets of transcriptional regulation by two distinct type 1 receptors for transforming growth factor-β in human umbilical vein endothelial cells , 2003 .